Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis

BackgroundVanishing bile duct syndrome is a rare drug-induced disease characterized by cholestasis and ensuing ductopenia. Dermatological manifestations of drug hypersensitivity such as Stevens-Johnson syndrome and toxic epidermal necrolysis may also present in such cases. Hemophagocytic lymphohisti...

Full description

Bibliographic Details
Main Authors: Wan-Chen Lin, Tyng-Shiuan Hsieh, Chia-Yu Chu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.975754/full
_version_ 1797990816663207936
author Wan-Chen Lin
Wan-Chen Lin
Tyng-Shiuan Hsieh
Tyng-Shiuan Hsieh
Chia-Yu Chu
Chia-Yu Chu
author_facet Wan-Chen Lin
Wan-Chen Lin
Tyng-Shiuan Hsieh
Tyng-Shiuan Hsieh
Chia-Yu Chu
Chia-Yu Chu
author_sort Wan-Chen Lin
collection DOAJ
description BackgroundVanishing bile duct syndrome is a rare drug-induced disease characterized by cholestasis and ensuing ductopenia. Dermatological manifestations of drug hypersensitivity such as Stevens-Johnson syndrome and toxic epidermal necrolysis may also present in such cases. Hemophagocytic lymphohistiocytosis is a hyperimmune response caused by unchecked stimulation of macrophages, natural killer cells, and cytotoxic T lymphocytes.Case presentationWe report a severe case who presented with concurrent Stevens-Johnson syndrome and vanishing bile duct syndrome complicated by hemophagocytic lymphohistiocytosis after the ingestion of non-steroidal anti-inflammatory drugs. Despite the fact that improvements in vanishing bile duct syndrome can be assumed when combining the clinical lab data clues, as well as repeated liver biopsies showing recovering ductopenia, the patient developed hypovolemic shock combined with septic shock episodes and died on day 236.ConclusionTo our knowledge, this is the fifteenth report of vanishing bile duct syndrome associated with Stevens-Johnson disease or toxic epidermal necrolysis. Mortality rate remains high without treatment guidelines established due to the rarity and heterogenicity of the population. Further studies are needed to identify possible risk factors, prognostic indicators, and the standard of care for vanishing bile duct syndrome associated with Stevens-Johnson disease or toxic epidermal necrolysis.
first_indexed 2024-04-11T08:42:20Z
format Article
id doaj.art-ba7beb867c4b4de6a54a7aa17bdf507b
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-11T08:42:20Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-ba7beb867c4b4de6a54a7aa17bdf507b2022-12-22T04:34:11ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-10-01910.3389/fmed.2022.975754975754Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosisWan-Chen Lin0Wan-Chen Lin1Tyng-Shiuan Hsieh2Tyng-Shiuan Hsieh3Chia-Yu Chu4Chia-Yu Chu5Department of Dermatology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Dermatology, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Dermatology, National Taiwan University College of Medicine, Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital, Taipei, TaiwanDepartment of Dermatology, National Taiwan University College of Medicine, Taipei, TaiwanBackgroundVanishing bile duct syndrome is a rare drug-induced disease characterized by cholestasis and ensuing ductopenia. Dermatological manifestations of drug hypersensitivity such as Stevens-Johnson syndrome and toxic epidermal necrolysis may also present in such cases. Hemophagocytic lymphohistiocytosis is a hyperimmune response caused by unchecked stimulation of macrophages, natural killer cells, and cytotoxic T lymphocytes.Case presentationWe report a severe case who presented with concurrent Stevens-Johnson syndrome and vanishing bile duct syndrome complicated by hemophagocytic lymphohistiocytosis after the ingestion of non-steroidal anti-inflammatory drugs. Despite the fact that improvements in vanishing bile duct syndrome can be assumed when combining the clinical lab data clues, as well as repeated liver biopsies showing recovering ductopenia, the patient developed hypovolemic shock combined with septic shock episodes and died on day 236.ConclusionTo our knowledge, this is the fifteenth report of vanishing bile duct syndrome associated with Stevens-Johnson disease or toxic epidermal necrolysis. Mortality rate remains high without treatment guidelines established due to the rarity and heterogenicity of the population. Further studies are needed to identify possible risk factors, prognostic indicators, and the standard of care for vanishing bile duct syndrome associated with Stevens-Johnson disease or toxic epidermal necrolysis.https://www.frontiersin.org/articles/10.3389/fmed.2022.975754/fullallergynon-steroidal anti-inflammatory drugsdrug-induced liver injuryvanishing bile duct syndromeStevens-Johnson syndromehemophagocytic lymphohistiocytosis
spellingShingle Wan-Chen Lin
Wan-Chen Lin
Tyng-Shiuan Hsieh
Tyng-Shiuan Hsieh
Chia-Yu Chu
Chia-Yu Chu
Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
Frontiers in Medicine
allergy
non-steroidal anti-inflammatory drugs
drug-induced liver injury
vanishing bile duct syndrome
Stevens-Johnson syndrome
hemophagocytic lymphohistiocytosis
title Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
title_full Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
title_fullStr Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
title_full_unstemmed Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
title_short Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosis
title_sort case report development of vanishing bile duct syndrome in stevens johnson syndrome complicated by hemophagocytic lymphohistiocytosis
topic allergy
non-steroidal anti-inflammatory drugs
drug-induced liver injury
vanishing bile duct syndrome
Stevens-Johnson syndrome
hemophagocytic lymphohistiocytosis
url https://www.frontiersin.org/articles/10.3389/fmed.2022.975754/full
work_keys_str_mv AT wanchenlin casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis
AT wanchenlin casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis
AT tyngshiuanhsieh casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis
AT tyngshiuanhsieh casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis
AT chiayuchu casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis
AT chiayuchu casereportdevelopmentofvanishingbileductsyndromeinstevensjohnsonsyndromecomplicatedbyhemophagocyticlymphohistiocytosis